Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
- PMID: 40697776
- PMCID: PMC12283192
- DOI: 10.1155/jdr/8096423
Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
Abstract
Objective: The objective of this study is to explore the association between MTHFR DNA methylation and diabetic kidney disease (DKD). Methods: This study involved 120 healthy people, 200 diabetes mellitus (DM) patients, and 200 DKD patients who visited China-Japan Friendship Hospital from 2022 to 2023. We selected four CpG islands for the detection of MTHFR DNA methylation: three located in the promoter region and one in Exon 2. The methylation rate of the MTHFR gene was measured using an enzyme digestion method combined with quantitative PCR. Clinical and biochemical characteristics between the two groups were also collected. Results: The methylation rate of the three CpG islands in the promoter region showed no significant differences between the DM and DKD patients. However, a significant difference in the CpG island methylation rate of the MTHFR gene Exon 2 was observed (25.14% vs. 21.94%, p < 0.001). Logistic regression analysis indicated that the methylation rate of MTHFR Exon2 is negatively associated with the occurrence and progression of DKD (OR = 0.947, 95% CI [0.919, 0.977], p = 0.001), with adjustments for gender, age, BMI, smoking, drinking, CHO, and TG. Significant differences were observed in the methylation ratios in different HCY groups (24.51% vs. 21.99%, p = 0.031). Linear regression showed MTHFR Exon 2 methylation negatively correlated with homocysteine (HCY) levels (p = 0.007). Conclusion: Methylation of the MTHFR gene Exon 2 is a protective factor for DKD and may contribute to its onset and progression through its influence on HCY levels. These findings highlight the potential of MTHFR methylation as a biomarker for DKD.
Keywords: DKD; DNA methylation; HCY; MTHFR.
Copyright © 2025 Guoxiong Deng et al. Journal of Diabetes Research published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Methylomic Changes in MTHFR Promoter Region, along with the Heterozygous C677T Polymorphism, Contribute to the Risk of Thrombotic Stroke.J Mol Neurosci. 2025 Jul 21;75(3):91. doi: 10.1007/s12031-025-02364-1. J Mol Neurosci. 2025. PMID: 40691374 Free PMC article.
-
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011. JBI Database System Rev Implement Rep. 2016. PMID: 27532796
-
Vitamin B and its derivatives for diabetic kidney disease.Cochrane Database Syst Rev. 2015 Jan 12;1(1):CD009403. doi: 10.1002/14651858.CD009403.pub2. Cochrane Database Syst Rev. 2015. PMID: 25579852 Free PMC article.
-
Interrelationships among MTHFR gene polymorphisms, MTRR gene polymorphisms, and HBV gene BCP 1762/1764 mutations with disease progression in Chronic hepatitis B virus infection patients.Nucleosides Nucleotides Nucleic Acids. 2025;44(8):697-715. doi: 10.1080/15257770.2024.2406223. Epub 2024 Sep 19. Nucleosides Nucleotides Nucleic Acids. 2025. PMID: 39297586
-
SNP-associated differential methylation in ARHGEF38: insights into genetic-epigenetic interactions.Epigenomics. 2025 Jun;17(9):579-588. doi: 10.1080/17501911.2025.2513215. Epub 2025 May 30. Epigenomics. 2025. PMID: 40444651
References
-
- Magliano D. J., Boyko E. J., IDF Diabetes Atlas 10th Edition Scientific Committee . IDF Diabetes Atlas . International Diabetes Federation; 2021. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous